• Research Professor, Global Health
Marcia Weaver

2301 5th Ave,
Suite 600
Seattle, WA 98121
United States

Phone Number: 
206-897-2861
Fax: 
206-897-2899
Email: 
mweaver@uw.edu
Select from the following:
Biography 

Marcia Weaver, PhD is an economist who leads the Cost-Effectiveness research team at UW’s Institute for Health Metrics and Evaluation. Recently, she was Principal Investigator for the Integrated Infectious Disease Capacity Building Evaluation (IDCAP), which was awarded to Accordia Global Health Foundation by the Bill and Melinda Gates Foundation. IDCAP was a cluster randomized trial implemented by the Infectious Diseases Institute in Uganda with the goal of evaluating the cost- effectiveness of two methods to build capacity among mid-level health practitioners for the treatment and prevention of HIV, malaria, pneumonia and tuberculosis. In the United States, Professor Weaver has published on cost-effectiveness of interventions for people with HIV and chronic mental illness and substance abuse as part of the ‘‘HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study,” and on a joint campaign to promote influenza and pneumococcal vaccines.

Professor Weaver has published 70 articles in peer-reviewed journals. A Full list of publications is available here

Education 
  • PhD (University of Chicago)
  • MA (University of Chicago)
  • BA (Hampshire College)
Country Affiliations 
Languages 
  • French
  • Mandarin
  • Spanish
Health Topics 
  • Burden of Disease
  • Cardiovascular Disease
  • Child and Adolescent Health (incl. Pediatrics)
  • Child Mortality
  • Chronic Disease (incl. Cardiovascular, Diabetes)
  • Clinical Mentoring
  • Cost-effectiveness
  • Diarrheal Diseases
  • Drug and Vaccine Development
  • Economics
  • Education and Training
  • Emergency Medicine
  • Health Economics
  • Health Interventions
  • Health Policy
  • Health Systems Strengthening and Human Resources Development
  • HIV/AIDS
  • Immunizations
  • Infectious Diseases
  • Malaria
  • Maternal Child Health (incl. Reproductive Health)
  • Metrics and Evaluation
  • Non-communicable diseases
  • Quality Improvement
  • STDs (other than HIV)
  • Stroke
  • TB
Publications 

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SE, et al. Cost-effectiveness analysis of integration of care for people with HIV, chronic mental illness and substance abuse disorders. Journal of Mental Health Economics and Policy, 2009; 12: 33-46.

Weaver MR, Crozier I, Eleku S, Makanga G, Sebuyira LM, Nyakake, Thompson ML, Willis K. Capacity-Building and Clinical Competence in Infectious Disease in Uganda: A Mixed-Design Study with Pre/Post and Cluster Randomized Trial Components. PLoS One 2012; 7(12):e51319. doi:10.1371/journal.pone.0051319

Weaver MR, Burnett SM, Crozier I, Kinoti SN, Kirunda I, Mbonye MK, Naikoba S, Ronald A, Rubashembusya T, Zawedde S, Willis KS. Improving facility performance in Infectious Disease Care in Uganda: a mixed design study with pre/post and cluster randomized trial components. PLoS One, 2014; 9(8): e103017. doi:10.1371/journal.pone.0103017

Galagan S, Jed SL, Sumitani J, Gilvydis J, Bakor A, Barnhart S, Cooke R, Naidoo E, Winters, D, Weaver MR. Improving TB and HIV care in South Africa: Evaluation of an advanced TB/HIV course for health care workers. Open Forum Infectious Disease. (2017) 4 (2): ofw248.

Geri G, Fahrenbruch C, Painter I, Rea TD, Weaver MW. Effects of bystander CPR following out-of-hospital cardiac arrest on hospital cost and long-term survival. Resuscitation. (2017) 11: 129–134